Clinical determinants of primary and secondary fatigue in patients with Parkinson's disease

Journal of Neurology

Volumn 260, Issue 6, 2013, Pages 1554-1561

  Skorvanek, Matej ^a,b   Nagyova, Iveta ^b   Rosenberger, Jaroslav ^b   Krokavcova, Martina ^a,b   Ghorbani Saeedian, Radka ^b   Groothoff, Johan W ^c   Gdovinova, Zuzana ^a   Van Dijk, Jitse P ^b,c  

^a L PASTEUR UNIVERSITY HOSPITAL   (Slovakia)

^b P J AFÁRIK UNIVERSITY   (Slovakia)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anxiety; Depression; Excessive daytime somnolence; Parkinson's disease; Primary fatigue; Secondary fatigue

Indexed keywords

AMANTADINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; RASAGILINE;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL ASSESSMENT; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DEMOGRAPHY; DEPRESSION; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE DURATION; EPWORTH SLEEPINESS SCALE; EXCESSIVE DAYTIME SOMNOLENCE; FATIGUE; FEMALE; FUNCTIONAL STATUS; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; MULTICENTER STUDY; MULTIDIMENSIONAL FATIGUE INVENTORY; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; PREDICTIVE VALUE; PREVALENCE; PRIMARY FATIGUE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SECONDARY FATIGUE; SEX DIFFERENCE; SLEEP QUALITY; SOCIAL ASPECT; SOMNOLENCE; SYMPTOM; UNIFIED PARKINSON DISEASE RATING SCALE;

AGED; ANXIETY; DEPRESSION; FATIGUE; FEMALE; HUMANS; MALE; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; PREVALENCE; PSYCHOLOGY; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX;

EID: 84878825840     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-012-6828-4     Document Type: Article

References (45)

1. Friedman JH, Abrantes A, Sweet LH (2011) Fatigue in Parkinson's disease. Expert Opin Pharmacother 13:1999-2007
2. Barone P, Antonini A, Colosimo C et al (2009) The PRIAMO study: a multicenter assessment of non-motor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 24:1641-1649
3. Havlikova E, Rosenberger J, Nagyova J, Middel B, Dubayova T, Gdovinova Z, van Dijk JP, Groothoff JW (2008) Impact of fatigue on quality of life in patients with Parkinson's disease. Eur J Neurol 15:475-480 (Pubitemid 351499193)
4. Gomez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Roucu I, Bustos JL, Valle MA, Lezcano E, Zarranz JJ (2011) Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease. J Neurol 258:494-499
5. Friedman JH, Friedman H (1993) Fatigue in Parkinson's disease. Neurology 43:2016-2018 (Pubitemid 23318871)
6. Trail M, Peterson NJ, Nelson N, Lai EC (2012) An exploratory study of activity in veterans with Parkinson's disease. J Neurol 259:1686-1693
7. Nisenzon AN, Robinson ME, Bowers D, Banou E, Malaty I, Okun MS (2011) Measurement of patient-centered outcomes in Parkinson's disease: what do patients really want from their treatment? Parkinsonism Relat Disord 2:89-94
8. van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijk JG, Roos RA (1993) Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neural Transm Park Dis Dement Sect 5:235-244 (Pubitemid 23227817)
9. Shulman LM, Taback R, Rabinstein AA, Weiner WJ (2002) Nonrecognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 8:193-197 (Pubitemid 33091403)
10. Brown RG, Dittner A, Findley L, Wessely SC (2005) The Parkinson fatigue scale. Parkinsonism Relat Disord 11:49-55 (Pubitemid 40037598)
11. Havlikova E, Rosenberger J, Nagyova I, Middel B, Dubayova T, Gdovinova Z, Groothoff JW, van Dijk JP (2008) Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease. Parkinsonism Relat Disord 14:187-192 (Pubitemid 351458420)
12. Hagell P, Brundin L (2009) Towards an understanding of fatigue in Parkinson disease. J Neurol Neurosurg Psychiatry 80:489-492
13. Karlsen K, Larsen JP, Tandberg E, Jorgensen K (1999) Fatigue in patients with Parkinson's disease. Mov Disord 14:237-241 (Pubitemid 30011839)
14. Lou JS, Kearns G, Oken B, Sexton G, Nutt J (2001) Exacerbated physical fatigue and mental fatigue in Parkinson's disease. Mov Disord 16:190-196 (Pubitemid 36049964)
15. Schifitto G, Friedman JH, Oakes D, Schulman L, Comella CL, Marek K, Fahn S (2008) Fatigue in levodopa-naive subjects with Parkinson disease. Neurology 71:481-485
16. Alves G, Wentzel-Larsen T, Larsen JP (2004) Is fatigue an independent and persistent symptom in patients with Parkinson's disease? Neurology 63:1908-1911 (Pubitemid 39532389)
17. Valko PO, Waldvogel D, Weller M, Bassetti CL, Held U, Baumann CR (2010) Fatigue and excessive daytime sleepiness in idiopathic Parkinson's disease differently correlate with motor symptoms, depression and dopaminergic treatment. Eur J Neurol 17:1428-1436
18. PVA (1998) Fatigue and multiple sclerosis: evidence-based management strategies for fatigue in multiple sclerosis. Paralyzed Veterans Association of America, Washington, DC
19. Friedman JH, Brown RG, Comella C et al (2007) Fatigue in Parkinson's disease: a review. Mov Disord 22:297-308 (Pubitemid 46569680)
20. Pavese N, Metta V, Bose SK, Chaudhuri KR, Brooks DJ (2010) Fatigue in Parkinson's disease is linked to striatal and limbic serotonergic dysfunction. Brain 133:3434-3443
21. Hughes AJ, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181-184
22. Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
23. Friedman JH, Alves G, Hagell P et al (2010) Fatigue rating scales critique and recommendations by the movement disorders society task force on rating scales for Parkinson's disease. Mov Disord 7:805-822
24. Schrag A, Barone P, Brown RG et al (2007) Depression rating scales in Parkinson's disease: critique and recommendations. Mov Disord 8:1077-1092 (Pubitemid 47067217)
25. Leentjens AFG, Dujardin K, Marsh L et al (2008) Anxiety rating scales in Parkinson's disease: critique and recommendations. Mov Disord 14:2015-2025
26. Hoegl B, Arnulf I, Comella C et al (2010) Scales to assess sleep impairment in Parkinson's disease: critique and recommendations. Mov Disord 16:2704-2716
27. Fahn S, Elton RL, Members of the UPDRS Development Committee (1987) Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Lieberman A (eds) Recent developments in Parkinson's disease, vol 2. MacMillan Healthcare Information, Florham Park, pp 153-163
28. Hoehn MM, Yahr MD (1967) Parkinsonism onset progression and mortality. Neurology 17:427-442
29. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE (2010) Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 25:2649-2653
30. Beck AT, Steer RA, Ball R, Ranieri W (1996) Comparison of Beck Depression Inventories -IA and -II in psychiatric outpatients. J Pers Assess 3:588-597 (Pubitemid 26382973)
31. Zigmond AS, Snaith RP (1983) The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370 (Pubitemid 13098606)
32. Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540-545
33. Buysse DJ, Reynolds CF 3rd, Monk TH, Berman SR, Kupfer DJ (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193-213 (Pubitemid 19144991)
34. Smets EMA, Grassen B, Bonke B, De Haes JCJM (1995) The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39:315-325
35. Elbers RG, van Wegen EEH, Verhoef J, Kwakkel G (2012) Reliability and structural validity of the multidimensional fatigue inventory (MFI) in patients with idiopathic Parkinson's disease. Parkinsonism Relat Disord 18:532-536
36. Reeves WC, Wagner D, Nisenbaum R et al (2005) Chronic fatigue syndrome - a clinically empirical approach to its definition and study. BMC Med 3:19
37. Avlund K (2010) Fatigue in older adults: an early indicator of the aging process? Aging Clin Exp Res 2:100-115
38. Herlofson K, Ongre SO, Enger LK, Tysnes OB, Larsen JP (2012) Fatigue in early Parkinson's disease. Minor inconvenience or major distress? Eur J Neurol 19:963-968
39. Martinez-Martin P, Pecurariu CF, Odin P, van Hilten JJ, Antonini A, Rojo-Abuin JM, Borges V, Trenkwalder C, Aarsland D, Brooks J, Chaudhuri KR (2012) Gender-related differences in the burden of non-motor symptoms in Parkinson's disease. J Neurol 259:1639-1647
40. Abe K, Takanashi M, Yanagihara T, Sakoda S (2001) Pergolide mesilate may improve fatigue in patients with Parkinson's disease. Behav Neurol 13:117-121 (Pubitemid 35407930)
41. Lou JS, Kearns G, Benice T, Oken B, Sexton G, Nutt J (2003) Levodopa improves physical fatigue in Parkinson's disease: a double-blind, placebo-controlled, crossover study. Mov Disord 18:1108-1114 (Pubitemid 37336933)
42. Hauser RA, Nausieda PA, Surmann E, Moran K, Barone P (2012) Rotigotine transdermal patch improved neuropsychiatric features (apathy, anhedonia, anxiety, and depression) and fatigue in patients with Parkinson's disease: Post hoc analysis of five double-blind placebo-controlled studies. Mov Disord 27(suppl.1):S271-S272
43. Martinez-Martin P, Catalan MJ, Benito-Leon J et al (2006) Impact of fatigue in Parkinson's disease: the Fatigue Impact Scale for Daily Use (D-FIS). Qual Life Res 15:597-606 (Pubitemid 43843968)
44. Mendonca D, Menezes K, Jog MS (2007) Methylphenidate improves fatigue scores in Parkinson's disease: a randomized controlled trial. Mov Disord 22:2070-2076
45. Zesiewicz TA, Sullivan KL, Arnulf I et al (2010) Practice Parameter: treatment of non-motor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 74:924-931